Fixed-dose combination
Showing 9976 - 10000 of >10,000
Cerebral Palsy, Hemiplegia Trial in White Plains (Upper Extremity Robotics, tDCS)
Active, not recruiting
- Cerebral Palsy
- Hemiplegia
- Upper Extremity Robotics, tDCS
-
White Plains, New YorkBurke Medical Research Institute
Oct 2, 2022
Depressive Disorder Trial in New York (Carbidopa/levodopa, Placebo, Exercise training)
Suspended
- Depressive Disorder
- Carbidopa/levodopa
- +3 more
-
New York, New YorkNew York State Psychiatric Institute
Jan 26, 2022
Vaccination; Infection, COVID-19 Trial (Comirnaty)
Not yet recruiting
- Vaccination; Infection
- COVID-19
- Comirnaty
- (no location specified)
Aug 4, 2023
Belatacept to Delay Tacrolimus Initiation in Kidney Transplant
Active, not recruiting
- Belatacept Impact on Patients With GDF
- impact of administering one dose of belatacept on eGFR
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- +3 more
- CCS1477
- +5 more
-
Boston, Massachusetts
- +21 more
Jan 10, 2023
Overweight, Obesity Trial in New Haven (Formulation A (PF-07081532 20 mg plus 60 mg), Formulation B (PF-07081532 80 mg))
Recruiting
- Overweight
- Obesity
- Formulation A (PF-07081532 20 mg plus 60 mg)
- Formulation B (PF-07081532 80 mg)
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jan 25, 2023
Advanced Malignancies, Non-small-cell Lung Cancer Trial in Worldwide (PF-06801591)
Active, not recruiting
- Advanced Malignancies
- Non-small-cell Lung Cancer
-
Beijing, Beijing, China
- +51 more
Jan 11, 2023
HER2/Neu Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Worldwide (drug, other, biological)
Active, not recruiting
- HER2/Neu Positive
- +8 more
- Cyclophosphamide
- +7 more
-
Anniston, Alabama
- +1291 more
Jan 28, 2023
Healthy Volunteers Trial in Shanghai (CMAB007, Xolair)
Completed
- Healthy Volunteers
- CMAB007
- Xolair
-
Shanghai, ChinaShanghai Xuhui Central Hospital
Jun 8, 2023
Bladder Cancer Trial in Seoul (hypo-IMRT)
Recruiting
- Bladder Cancer
- hypo-IMRT
-
Seoul, Korea, Republic ofSamsung Medical Center
Jul 6, 2022
Acute Gastroenteritis Trial in Liuzhou (Low-dose vaccine, High-dose vaccine, Placebo (containing aluminum))
Recruiting
- Acute Gastroenteritis
- Low-dose vaccine
- +3 more
-
Liuzhou, Guangxi, ChinaLiuzhou Center for Disease Control and Prevention
Sep 2, 2022
Drug Drug Interaction Trial in Seoul (DWP14012, DWC202202, DWC202203)
Recruiting
- Drug Drug Interaction
- DWP14012
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 6, 2022
Healthy Trial in Adelaide (ENN0403 1mg, ENN0403 4mg, ENN0403 10mg)
Completed
- Healthy
- ENN0403 1mg
- +9 more
-
Adelaide, AustraliaCMAX Clinical Research Pty Ltd
Aug 17, 2022
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Trial in Jordan, Kenya, Lebanon (INO-4700, Placebo, CELLECTRA™ 2000)
Completed
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
- INO-4700
- +2 more
-
Irbid, Jordan
- +5 more
Jan 27, 2023
Alzheimer's Disease Trial in Decatur (AL 001, Placebo)
Recruiting
- Alzheimer's Disease
- Healthy Non-elderly and Elderly Adults
- AL 001
- Placebo
-
Decatur, Georgia
- +1 more
Jan 10, 2023
Hearing Loss, Tinnitus, Sensorineural Hearing Loss Trial (Prednisone tablet, Ginkgo Biloba Extract)
Not yet recruiting
- Hearing Loss
- +2 more
- Prednisone tablet
- Ginkgo Biloba Extract
- (no location specified)
Nov 8, 2023
Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Refractory High Risk Myelodysplastic Syndrome Trial in
Completed
- Myelodysplastic Syndrome
- +4 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 11, 2021
Cognitive Deficit in Attention, Executive Dysfunction, Emotional Regulation Trial in Ithaca (Maternal Choline Supplementation
Not yet recruiting
- Cognitive Deficit in Attention
- +2 more
- Maternal Choline Supplementation 930 mg/d
- Maternal Choline Supplementation 480 mg/d
-
Ithaca, New YorkCornell University, Division of Nutritional Sciences
May 12, 2023
Metastatic Castration-resistant Prostate Cancer Trial in United States (AMG 340)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- AMG 340
-
San Francisco, California
- +6 more
Jul 14, 2022
Corona Virus Disease Trial in United States (AZD7442, AZD8895 (clonal cell line material), AZD1061 (clonal cell line material))
Active, not recruiting
- Corona Virus Disease
- AZD7442
- +4 more
-
Anniston, Alabama
- +12 more
Aug 12, 2022